Immix Biopharma, Inc.IMMXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-40.48%
↑ 70% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-132.76%
Historical baseline
PeriodValue
2024-40.48%
2023-96.39%
2022-507.90%
2021-197.90%
202046.13%
20190.00%